ReviewProbiotics and antimicrobial proteins2026
Plant Antimicrobial Peptides and Bacteriocins: Emerging Strategies Against Biofilms.
Review in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial Peptides (AMPs) are widely distributed and serve as innate immune responses in various organisms to combat a broad range of pathogens. Bacteriocins are narrow-spectrum antibacterial agents that are found to exhibit bactericidal effects against closely related bacteria of the strain that produces them. The expression of AMPs in plants is considered to be induced by the invasion of pathogenic microorganisms. Thus, the AMPs in plants are part of the immunological response to counter the infection caused by a variety of microorganisms. Biofilms pose a significant challenge in treatment due to their ability to adapt and develop resistance to antibiotics, which is more pronounced than their planktonic counterparts. In this review, AMPs are being explored as potential alternative agents to conventional antibiotics in the quest to combat chronic infections caused by biofilms. AMPs can be potentially effective strategy for fighting infections caused by biofilms. This is because many AMPs specifically target the microbial membrane, making them potentially effective even against cells that are not actively metabolizing. We have also explored the possible mechanisms involved in the eradication of biofilm, which include interference with cell wall and cell membrane-related processes, inhibiting the attachment of microorganisms to the surface, and disrupting cell-to-cell communication within the biofilm.
Indexed as
Identifiers
42489774What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.